Parapsoriasis en Plaque is a chronic skin disorder characterized by the presence of scaly, erythematous (red) plaques on the skin. It is considered as an early stage of cutaneous T-cell lymphoma, a type of non-Hodgkin's lymphoma involving the skin.
The condition typically affects adults, predominantly in their middle age, and is more commonly seen in males. The exact cause of Parapsoriasis en Plaque is unknown, although it is believed to involve an abnormal immune response and genetic factors.
Clinically, the condition presents as well-demarcated, pink to red patches or plaques on the trunk, buttocks, or limbs. These lesions are usually dry, scaly, and may become thickened over time. They can be mildly itchy but are generally asymptomatic. Over time, the plaques may darken in color and have a yellowish-brown hue.
Diagnosis of Parapsoriasis en Plaque involves a thorough clinical evaluation, along with a skin biopsy to confirm the presence of atypical T-lymphocytes. Other investigations such as blood tests and imaging may be conducted to rule out associated systemic involvement.
Treatment options for Parapsoriasis en Plaque aim to control symptoms and slow the progression of the disease. The approach may include topical corticosteroids and emollients to relieve itching and moisturize the skin. Phototherapy with ultraviolet B or psoralen plus ultraviolet A (PUVA) may be employed to help clear the plaques. Systemic therapies such as methotrexate or retinoids may be recommended in more severe cases.
Regular follow-up with a dermatologist is crucial to monitor the progression of Parapsoriasis en Plaque and to manage any potential complications or progression to more advanced
